SM22α-hSIRT6/ApoE−/− mice had reduced atherosclerosis, markers of senescence and inflammation compared with littermate controls, while plaques of SM22α-hSIRT6H133Y/ApoE−/− mice showed increased features of plaque instability. Here, SIRT6 is linked to atherosclerosis.